| Peer-Reviewed

Obesity as a Risk Factor Against COVID-19

Received: 22 April 2021     Accepted: 21 May 2021     Published: 31 May 2021
Views:       Downloads:
Abstract

In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.

Published in Science Journal of Clinical Medicine (Volume 10, Issue 2)
DOI 10.11648/j.sjcm.20211002.13
Page(s) 30-37
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

COVID-19, Obesity, Risk Factors, Comorbidity

References
[1] WHO. WHO | Obesity. WHO [Internet]. 2016 [cited 2021 Mar 25]; Available from: http://www.who.int/topics/obesity/es/
[2] OPS. Coronavirus (COVID-19) events as they happen [Internet]. WORLD HEALTH ORGANITATION. 2020 [cited 2021 Mar 25]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
[3] Clemmensen C, Petersen M, Sørensen A. Will the COVID-19 pandemic worsen the obesity epidemic? comment [Internet]. 2020; 16. Available from: https://www.
[4] Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020; 43 (7): 1392–8.
[5] Sattar N, McInnes IB, McMurray JJV. Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation. 2020; 44 (0): 4-6.
[6] Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission [Internet]. Vol. 71, Clinical Infectious Diseases. Oxford University Press; 2020 [cited 2021 Mar 25]. p. 896–7. Available from: https://academic.oup.com/cid/article/71/15/896/5818333
[7] Petrilli C, Jones S, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City. medRxiv. 2020; (646): 1–25.
[8] Gao F, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, et al. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020; 43 (7): E72–4.
[9] Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018 Key findings Data from the National Health and Nutrition Examination Survey [Internet]. 2017 [cited 2021 Mar 25]. Available from: https://www.cdc.gov/nchs/products/index.htm.
[10] Marques A, Peralta M, Naia A, Loureiro N, De Matos MG. Prevalence of adultoverweight and obesity in 20 European countries, 2014. Eur J Public Health. 2018; 28 (2): 295–300.
[11] González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, et al. Obesity. Nat Rev Dis Prim. 2017; 3.
[12] Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109 (5): 531–8.
[13] Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity. 2020; 28 (7): 1195-9.
[14] Xiang T, Liu J XF. Analysis of clinical characteristics of 49 patients with coronavirus disease 2019 in Jiangxi [Internet]. Epistemonics. 2020 [cited 2021 Mar 25]. Available from: https://www.epistemonikos.org/documents/dbcd5d8a417acff834a4a01e025657387fc1159f
[15] EL-Arabey AA, Abdalla M. Metformin and COVID-19: A novel deal of an old drug. J Med Virol. 2020; 92 (11): 2293–4.
[16] Health E for public, Istituto Superiore di Sanità. Characteristics of SARS-CoV-2 patients dying in Italy Report. ISTITVTO SVPERIORE DI SANITA [Internet]. 2020; 4–8. Available from: https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-analysis-of-deaths%0A https://www.epicentro.iss.it/en/coronavirus/bollettino/Report -COVID-2019_7_september_2020.pdf
[17] Campoverde ME, Añez R, Salazar J, Rojas J, Bermúdez V. Risk factors for obesity in adults from the city of Cuenca, Ecuador. Rev Latinoam Hipertens. 2016; 9 (3): 1–10.
[18] Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, et al. Body-mass index and all-cause mortality: individual-participant-datameta-analysis of 239 prospective studies in four continents. Lancet. 2016; 388 (10046): 776-86.
[19] Secretan BL, Ph D, Scoccianti C, Ph D, Loomis D, Ph D. Spe ci al R ep or t Body Fatness and Cancer - Viewpoint of the IARC Working Group. Med Spec. 2016; (Copyright): 794–8.
[20] Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity. 2020; 28 (6): 1005.
[21] Pinazo-hernandis S. DAD E SPA AT Y GER ON TO Psychosocial impact of COVID-19 on older people: problems and challenges Psychosocial impact of COVID-19 on older people: Problems and challenges. Rev Esp Geriatr Gerontol [Internet]. 2020; 55 (5): 249–52. Available from: https://doi.org/10.1016/j.regg.2020.05.006
[22] Hussain A, Mahawar K, Xia Z, Yang W, EL-Hasani S. Obesity and mortality of COVID-19. Meta-analysis. Obes Res Clin Pract [Internet]. 2020; 14 (4): 295–300. Available from: https://doi.org/10.1016/j.orcp.2020.07.002
[23] Muscogiuri G, Pugliese G, Barrea L, Savastano S, Colao A. Commentary: Obesity: The & quot; Achilles heel & quot; for COVID-19? Metabolism [Internet]. 2020; 108 (January): 154251. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32353356%0A http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC7184987
[24] Peres IT, Bastos LSL, Gelli JGM, Marchesi JF, Dantas LF, Antunes BBP. Since January 2020 Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource center is hosted on Elsevier Connect, the company 's public news and information. Public Health. 2020; (January).
[25] Frühbeck G, Busetto L, Dicker D, Yumuk V, Goossens GH, Hebebrand J, et al. The ABCD of obesity: An EASO position statement on a diagnostic term with clinical and scientific implications. Obes Facts. 2019; 12 (2): 131–6.
[26] Global Health. The Sex, Gender and COVID-19 Project | Global Health 50/50 [Internet]. March. 2021 [cited 2021 Mar 25]. Available from: https://globalhealth5050.org/the-sex-gender-and-covid-19-project/
[27] Davies NG, Klepac P, Liu Y, Prem K, Jit M, Eggo RM, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. medRxiv. 2020.
[28] Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Aging Res Rev. 2021; 65 (January).
[29] Wensveen FM, Valentić S, Šestan M, Turk Wensveen T, Polić B. The “Big Bang” in obese fat: Events initiating obesity-induced adipose tissue inflammation. Eur J Immunol. 2017; 45 (9): 2446–56.
[30] Belančić A, Kresović A, Rački V. Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity. Obes Med [Internet]. 2020; 19 (May): 100259. Available from: https://doi.org/10.1016/j.obmed.2020.100259
[31] Lee-Cervantes DE, Sánchez-Jiménez BA, Gutiérrez-Grobe Y, Yeverino-Suárez P, Juárez-Hernández E, Chávez-Tapia NC. Clinical effect of obesity in the treatment of abdominal pain in the emergency department. Med Interna Mex. 2016; 30 (5): 546–53.
[32] Ahn SY, Sohn SH, Lee SY, Park HL, Park YW, Kim H, et al. The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology. Environ Toxicol Pharmacol [Internet]. 2015; 40 (3): 924–30. Available from: http://dx.doi.org/10.1016/j.etap.2015.09.020
[33] Alves A, Quispe A, Ávila A, Valdivia A, Chino J, Vera O. Brief history and pathophysiology of COVID-19. Diagnostic Guide and COVID-19 Treatment in Ter Intensive Units for Boliv [Internet]. 2020; 61 (1): 77–86. Available from: http://www.scielo.org.bo/scielo.php?pid=S1652-67762020000100011&script=sci_arttext
[34] Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet [Internet]. 2021; 6736 (21): 1-12. Available from: http:///dx.doi.org/10.1016/S0140-6736(21)00306-8
[35] Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet [Internet]. 2020; 395 (10236): 1544-5. Available from: http:///dx.doi.org/10.1016/S0140-6736(20)31024-2
[36] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020; 395 (10229): 1054-62. Available from: http:///dx.doi.org/10.1016/S0140-6736 (20) 30566-3
[37] Mehanna O, Askary A El, Ali E, Esawy B El, Fathalla T, Gharib AF. Impact of obesity and its associated comorbid conditions on COVID-19 presentation. Diabetes, Metab Syndr Obes Targets Ther. 2021; 14: 409-15.
[38] Afolabi HA, Zakariya Z bin, Ahmed Shokri A Bin, Mohammad Hasim MN Bin, Vinayak R, Afolabi-Owolabi OT, et al. The relationship between obesity and other medical comorbidities. Obes Med [Internet]. 2020; 17 (November 2019): 100164. Available from: https://doi.org/10.1016/j.obmed.2019.100164
[39] Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19. Aging (Albany NY). 2020; 12 (7): 6049-57.
[40] Goossens GH. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017; 10 (3): 207–15.
[41] Cândido FG, Valente FX, Grześkowiak ŁM, Moreira APB, Rocha DMUP, Alfenas R de CG. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. Int J Food Sci Nutr [Internet]. 2018; 69 (2): 125–43. Available from: https://doi.org/10.1080/09637486.2017.1343286
[42] Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med [Internet]. 2020; 19 (July): 100283. Available from: https://doi.org/10.1016/j.obmed.2020.100283
[43] Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020; 251 (3): 228-48.
[44] Bello-Chavolla OY, González-Díaz A, Antonio-Villa NE, Fermín-Martínez CA, Márquez-Salinas A, Vargas-Vázquez A, et al. Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging. Journals Gerontol Ser A. 2020; 76 (3): 52–9.
[45] Upadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a Disease. Med Clin North Am [Internet]. 2018; 102 (1): 13–33. Available from: https://doi.org/10.1016/j.mcna.2017.08.004
[46] Pranata R, Lim MA, Yonas E, Vania R, Lukito AA, Siswanto BB, et al. Body mass index and outcome in patients with COVID-19: A dose – response meta-analysis. Diabetes Metab [Internet]. 2020; 1–9. Available from: https://doi.org/10.1016/j.diabet.2020.07.005
[47] Petrova D, Salamanca-Fernández E, Rodríguez Barranco M, Navarro Pérez P, Jiménez Moleón JJ, Sánchez MJ. Obesity as a risk factor in COVID-19: Possible mechanisms and implications. Aten Primaria [Internet]. 2020; 52 (7): 496-500. Available from: https://doi.org/10.1016/j.aprim.2020.05.003
[48] Velázquez LC. COVID-19: a challenge for global science. An Acad Ciencias Cuba. 2020; 10 (2): 763.
[49] Lázaro Díaz-Rodríguez Y, Amado Quintana-López L. “COVID-19. From pathogenesis to high mortality in the elderly and with comorbidities. " Rev Habanera Medical Sciences [Internet]. 2020 [cited 2021 Mar 26]; 19. Available from: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3531
[50] Rico J, Daza R, Galvis N, Martínez V, Franco E, López J, et al. Obesity and Covid-19. Arch Medi. 2020; 16 (4): 1–5.
[51] Salinas-Aguirre JE, Sánchez-García C, Rodríguez-Sanchez R, Rodríguez-Muñoz L, Díaz-Castaño A, Bernal-Gómez R. Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico). Rev Clínica Española. 2021; (1): 6–10.
Cite This Article
  • APA Style

    Rosa Elvira Minchala Urgilés, Anabel Estefanía Arce Prieto, Andrés Alexis Ramírez Coronel, Lilia Romero Sacoto, Fanny González León, et al. (2021). Obesity as a Risk Factor Against COVID-19. Science Journal of Clinical Medicine, 10(2), 30-37. https://doi.org/10.11648/j.sjcm.20211002.13

    Copy | Download

    ACS Style

    Rosa Elvira Minchala Urgilés; Anabel Estefanía Arce Prieto; Andrés Alexis Ramírez Coronel; Lilia Romero Sacoto; Fanny González León, et al. Obesity as a Risk Factor Against COVID-19. Sci. J. Clin. Med. 2021, 10(2), 30-37. doi: 10.11648/j.sjcm.20211002.13

    Copy | Download

    AMA Style

    Rosa Elvira Minchala Urgilés, Anabel Estefanía Arce Prieto, Andrés Alexis Ramírez Coronel, Lilia Romero Sacoto, Fanny González León, et al. Obesity as a Risk Factor Against COVID-19. Sci J Clin Med. 2021;10(2):30-37. doi: 10.11648/j.sjcm.20211002.13

    Copy | Download

  • @article{10.11648/j.sjcm.20211002.13,
      author = {Rosa Elvira Minchala Urgilés and Anabel Estefanía Arce Prieto and Andrés Alexis Ramírez Coronel and Lilia Romero Sacoto and Fanny González León and María De Los Ángeles Estrella-González and Pedro Carlos Martínez-Suárez},
      title = {Obesity as a Risk Factor Against COVID-19},
      journal = {Science Journal of Clinical Medicine},
      volume = {10},
      number = {2},
      pages = {30-37},
      doi = {10.11648/j.sjcm.20211002.13},
      url = {https://doi.org/10.11648/j.sjcm.20211002.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20211002.13},
      abstract = {In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Obesity as a Risk Factor Against COVID-19
    AU  - Rosa Elvira Minchala Urgilés
    AU  - Anabel Estefanía Arce Prieto
    AU  - Andrés Alexis Ramírez Coronel
    AU  - Lilia Romero Sacoto
    AU  - Fanny González León
    AU  - María De Los Ángeles Estrella-González
    AU  - Pedro Carlos Martínez-Suárez
    Y1  - 2021/05/31
    PY  - 2021
    N1  - https://doi.org/10.11648/j.sjcm.20211002.13
    DO  - 10.11648/j.sjcm.20211002.13
    T2  - Science Journal of Clinical Medicine
    JF  - Science Journal of Clinical Medicine
    JO  - Science Journal of Clinical Medicine
    SP  - 30
    EP  - 37
    PB  - Science Publishing Group
    SN  - 2327-2732
    UR  - https://doi.org/10.11648/j.sjcm.20211002.13
    AB  - In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.
    VL  - 10
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador

  • Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador

  • Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador

  • Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador

  • Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador

  • Laboratory of Psychometry and Cognitive Neurosciences of the Center for Research, Innovation and Technology Transfer, Catholic University of Cuenca, Cuenca, Ecuador

  • Sections